| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
- Ketoprofen Lysinate
-
- $1.50
-
2026-05-26
- CAS:57469-78-0
- Min. Order: 1g
- Purity: 99.0% Min
- Supply Ability: 10 Tons
- Ketoprofen lysinate
-
-
2025-12-24
- CAS:57469-78-0
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 10000KG
- Ketoprofen lysinate
-
- $120.00
-
2023-06-26
- CAS:57469-78-0
- Min. Order: 10g
- Purity: >99%
- Supply Ability: 500kg/month
|
| | Ketoprofen lysinate Basic information |
| Product Name: | Ketoprofen lysinate | | Synonyms: | 2-(3-benzoylphenyl)propanoic acid: (2R)-2,6-diaminohexanoic acid;2-(3-Benzoylphenyl)propanoic acid lysine salt;Ketoprofen lysine salt;Lysyl-ketoprofen;Ketoprofen lysinate;Lysine salt;Ketoprofen lysinate USP/EP/BP;Ketoprofen lysineQ: What is
Ketoprofen lysine Q: What is the CAS Number of
Ketoprofen lysine Q: What is the storage condition of
Ketoprofen lysine Q: What are the applications of
Ketoprofen lysine | | CAS: | 57469-78-0 | | MF: | C16H14O3.C6H14N2O2 | | MW: | 400.47 | | EINECS: | | | Product Categories: | | | Mol File: | 57469-78-0.mol |  |
| | Ketoprofen lysinate Chemical Properties |
| | Ketoprofen lysinate Usage And Synthesis |
| Uses | Ketoprofen Lysinate is a non-steroidal anti-inflammatory drug used in the symptomatic treatment of some chronic inflammatory diseases. An anti-inflammatory agent. | | in vivo | Ketoprofen lysinate (Oral administration, 10 mg/kg, three times a week for 10 weeks, HFD-induced obese C57BL/6 mice) decreases in relative body weight (15.41%), the iWAT mass (approximately 41%), and leptin (58.68%) and resistin (12.88%)[2].
Ketoprofen lysinate (50 mg/kg, LPS-treated dairy cows) lowers the increase of somatic cell count (SCC), serum albumin (SA), IgG and lactate dehydrogenase (LDH) activity in milk induced by LPS[3]. | Animal Model: | HFD-induced obese C57BL/6 mice[2] | | Dosage: | 10 mg/kg | | Administration: | Oral administration, three times a week for 10 weeks | | Result: | Decreased in relative body weight, the iWAT mass, and the level of leptin and resistin. |
| Animal Model: | LPS (0.2 μg/mL)-treated dairy cows [3] | | Dosage: | 50 mg/kg | | Administration: | Injection (Milk samples were taken every 30 min until 6 and 9 h) | | Result: | Lowered the increase of somatic cell count (SCC), serum albumin (SA), IgG and lactate dehydrogenase (LDH) activity in milk. |
| | IC 50 | COX-1: 2 nM (IC50); COX-2: 26 nM (IC50) |
| | Ketoprofen lysinate Preparation Products And Raw materials |
|